Philip T. Ninan, MD
- 29Articles
- 98.3KReads
- 1997–2016Active
- 96Collaborators
- 298Citations
About
Philip T. Ninan, MD, has authored numerous articles focused on major depressive disorder, anxiety, and related psychiatric conditions. His work includes studies on pharmacotherapy augmentation, antidepressant efficacy, and management of depression in perimenopausal and postmenopausal women. He has also contributed to research on the safety and clinical outcomes of specific antidepressants such as desvenlafaxine and venlafaxine. His publications span topics including obsessive-compulsive disorders, schizophrenia spectrum disorders, and anxiolytics.
Publications
Incidence and Timing of Taper/Posttherapy-Emergent Adverse Events Following Discontinuation of Desvenlafaxine 50 mg/d in Patients With Major Depressive Disorder
February 5, 2015
Remission With Venlafaxine Extended Release or Selective Serotonin Reuptake Inhibitors in Depressed Patients: A Randomized, Open-Label Study
February 24, 2011
Depression or Menopause? Presentation and Management of Major Depressive Disorder in Perimenopausal and Postmenopausal Women
February 18, 2010
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
